(Q41094696)

26 September 2017

title

Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo (English)

1 reference

26 September 2017

1 reference

M J O'Neill

1

1 reference

26 September 2017

C P Bath

2

1 reference

26 September 2017

C P Dell

3

1 reference

26 September 2017

C A Hicks

4

1 reference

26 September 2017

J Gilmore

5

1 reference

26 September 2017

S J Ambler

6

1 reference

26 September 2017

M A Ward

7

1 reference

26 September 2017

D Bleakman

8

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

European Journal of Pharmacology

26 September 2017

published in

1 reference

26 September 2017

volume

332

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

121-131

1 reference

Drugs acting on calcium channels: potential treatment for ischaemic stroke

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Pharmacological profile of a novel neuronal calcium channel blocker includes reduced cerebral damage and neurological deficits in rat focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Characteristics of a human N-type calcium channel expressed in HEK293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

7 January 2021

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Sodium and potassium conductances in somatic membranes of rat Purkinje cells from organotypic cerebellar cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Failure of levemopamil to improve histological outcome following temporary occlusion of the middle cerebral artery in cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Omega-conotoxin MVIIC reversibly inhibits a human N-type calcium channel and calcium influx into chick synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Protection against post-ischemic behavioral pathology by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) in the gerbil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

(S)-emopamil protects against global ischemic brain injury in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

P-type calcium channels blocked by the spider toxin ω-Aga-IVA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Postischemic (S)-emopamil therapy ameliorates focal ischemic brain injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

(S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Neuronal protective effects of calcium antagonists in cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Na+ channels as targets for neuroprotective drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Reflections on Ca(2+)-channel diversity, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901074-1

10.1016/S0014-2999(97)01074-1

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference